COV — CLEO Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$56.54m
- AU$49.23m
- AU$0.60m
- 55
- 12
- 58
- 39
Annual cashflow statement for CLEO Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Changes in Working Capital | — | — | 0.56 |
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 0 | -0.684 | -2.03 |
| Capital Expenditures | -0.2 | -0.34 | -0.003 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Cash from Investing Activities | -0.2 | -0.34 | -0.003 |
| Financing Cash Flow Items | — | -0.182 | -0.834 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.243 | 1.22 | 11.2 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.043 | 0.197 | 9.13 |